putrescine has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motyl, T | 1 |
| Kasterka, M | 1 |
| Grzelkowska, K | 1 |
| Blachowski, S | 1 |
| Sysa, P | 1 |
| Shardakov, VI | 1 |
| Dem'ianova, VT | 2 |
| Pankov, VN | 1 |
| Sitnikov, SA | 1 |
| Voronchikhína, LD | 1 |
| Kostiaev, AA | 1 |
| Berdinskikh, NK | 1 |
| Beznosikova, TP | 1 |
3 other studies available for putrescine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
TGF-beta 1 inhibits polyamine biosynthesis in K 562 leukemic cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosylmethionine Decarboxylase; Apoptosis; Cell Div | 1993 |
[Polyamine and middle-molecule peptide levels in patients with chronic myeloid leukemia during treatment].
Topics: Antineoplastic Agents; Drug Resistance; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ne | 1990 |
[Fractional composition of free polyamines in the bone marrow and peripheral blood leukocytes in healthy persons and in patients with chronic leukemia].
Topics: Bone Marrow; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL | 1988 |